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We report C. kefyr as the causative pathogen in a case of fungal enteritis, diagnosed both by histology and nucleic acid sequencing, and describe its possible emerging role as a pathogen in patients with haematological malignancies.
A 59-year-old man presented with fever and abdominal pain at 4 weeks following a BEAM autologous BMT for Waldenstrom's macrogloblinaemia, previously treated with six cycles of R-CHOP chemotherapy to complete response. He was neutropenic for a total of 10 days and received no routine systemic antifungal prophylaxis. Repeated blood cultures were negative and the fever was unresponsive to empirical antibiotic therapy. Computerised tomography of the sinuses, chest, abdomen and pelvis suggested small bowel obstruction (Figure 1a) , with a possible fungal infection of the sinuses but normal lung fields (not shown). He was commenced on liposomal amphotericin B (3 mg/kg once daily i.v.), but the gastrointestinal symptoms worsened, requiring a strictuloplasty, mid-jejunal resection and ileostomy formation. Histology from the resected jejunum revealed multiple areas of ulceration with small ''volcanolike'' lesions containing invasive fungal hyphae and spores (Figures 1b and c) . These unexpected findings of invasive fungal infection prompted escalation of the liposomal amphotericin dose to 5 mg/kg once daily i.v. and the addition of oral posaconazole (200 mg, four times daily).
In the absence of unfixed specimens, DNA was extracted from formalin-fixed jejunal tissue using previously published TaKaRa DEXPAT method (TaKaRa, Madison, WI, USA). 5 Amplification and sequencing of the 18S ribosomal RNA gene was performed using pan-fungal primers described by Einsele et al. 6 The PCR of 18S ribosomal RNA resulted in a 429-bp fragment, which was compared against sequences in the GenBank database. The fragment shared 100% sequence homology with Kluyveromyces marxianus (teleomorph of C. kefyr) partial 18S ribosomal RNA gene (E-value ¼ 0.0, indicating a highly statistically significant species identification).
He was treated with posaconazole for 2 weeks and liposomal amphotericin for 4 weeks. He had a reversal in his ileostomy after 10 months and is currently well.
Invasive fungal enteritis is a rare complication in immunocompromised patients, sometimes diagnosed only at autopsy. The true incidence of these infections may be underestimated in life. Diagnosis can be delayed because of its nonspecific presentation as well as the lack of characteristic imaging. Accordingly, its true nature may only be revealed either at or following surgery. Among BMT recipients, both Aspergillus and a variety of Candida albican species can cause invasive fungal infections. 7 The discovery of fungal elements deep within tissue, often unexpectedly, can be diagnostic. Further histological speciation to taxon level remains difficult and unreliable, especially when important morphological elements of size, branching angle and septation may have been distorted by previous antifungal therapy, as in this case.
Recent studies have demonstrated disseminated C. kefyr infections in patients with haematological malignancies in which the reported incidence is twice as high when compared with patients in non-haematological wards. Both amphotericin-based products and caspofungin have been used successfully for treatment, and in vitro data indicate that C kefyr remains susceptible to both these agents. Others, however, have suggested that some strains may not be as susceptible to amphotericin while preserving susceptibility to posaconazole. 9, 10 In the absence of a live isolate for sensitivity testing we cannot state whether addition of oral posaconazole was of any additional benefit in our case, although it would have been present in high concentrations at the site of invasive infection. Furthermore, the extensive duodenal ulceration occurring post-operatively (Figure 1d ) and resulting gastrointestinal haemorrhage is a recognised complication of fungal enteritis and was suggestive of active infection, despite negative histology.
Fungal enteritis is a rare disease with a high-associated mortality and no established optimal treatment. Surgery may be both therapeutic and diagnostic, and subsequent anti-mycotic therapy may be relevant to outcome. We have identified C. kefyr as a cause of fungal enteritis through primer-specific nucleic acid sequencing from tissueembedded paraffin blocks, in the absence of positive blood cultures contributing to the growing evidence that C. kefyr is an emerging pathogen in oncohaematological patients. Its true incidence may only be revealed by a systematic study of acute gastrointestinal complications in patients undergoing treatment for haematological malignancy.
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